The immune system protects the body from pathogens through a variety of defences. It contains specialized cells like phagocytes and lymphocytes that recognize and eliminate pathogens. Lymphocytes include B cells which produce antibodies and T cells such as cytotoxic T cells that kill infected cells and helper T cells that coordinate the immune response. The immune system also contains physical, physiological, cellular and cytokine barriers as part of the innate immune system. When these are breached, the acquired immune system responds through cellular and humoral immunity mediated by T and B cells. Autoimmune diseases occur when this system mistakenly attacks the body's own cells.
primary,secondary immune response, immunoglobulins, antibodies, B cells, T cells, B lymphocytes, T lymphocytes,Interleukins, cytokines, MHC complex, cell surface receptors, Vaccination
primary,secondary immune response, immunoglobulins, antibodies, B cells, T cells, B lymphocytes, T lymphocytes,Interleukins, cytokines, MHC complex, cell surface receptors, Vaccination
ANTIGEN PROCESSING PRESENTATION AND RECOGNITION - Copy [Autosaved].pptxSamboZailani1
This is a medical students' lecture.
It is among the immunology lectures. it is important for a medical student to understand immunology to some extent.
introduction of adaptive immunity. classification of adaptive immunity, factor affecting it and mechanism of adaptive immunity comparison between adaptive immunity and innate immunity. characteristic of adaptive immunity . cell mediated immune responses immunoglobulins
types of immunoglobulins. functions of immunoglobulins, hypersensitivity reactions
ANTIGEN PROCESSING PRESENTATION AND RECOGNITION - Copy [Autosaved].pptxSamboZailani1
This is a medical students' lecture.
It is among the immunology lectures. it is important for a medical student to understand immunology to some extent.
introduction of adaptive immunity. classification of adaptive immunity, factor affecting it and mechanism of adaptive immunity comparison between adaptive immunity and innate immunity. characteristic of adaptive immunity . cell mediated immune responses immunoglobulins
types of immunoglobulins. functions of immunoglobulins, hypersensitivity reactions
The immune system has evolved to protect the host from a universe of pathogenic microbes that are themselves constantly evolving. The immune system also helps the host eliminate toxic or allergenic substances that enter our body. It is a host defence system comprising many biological structures and processes within an organism that protects against disease. To function properly, an immune system must detect a wide variety of agents, known as pathogens, from viruses to parasitic worms, and distinguish them from the organism's own healthy tissue. The host uses both innate and adaptive mechanisms to detect and eliminate pathogenic foreign bodies. Both of these mechanisms include self-nonself discrimination.
The main parts of the immune system are:
• White Blood Cells
• Antibodies
• Complement System
• Lymphatic System
• Spleen
• Bone Marrow
• Thymus.
Difference between humoral and cell mediated immunity Dr. ihsan edan abdulkar...dr.Ihsan alsaimary
Dr. ihsan edan abdulkareem alsaimary
PROFESSOR IN MEDICAL MICROBIOLOGY AND MOLECULAR IMMUNOLOGY
ihsanalsaimary@gmail.com
mobile : 009647801410838
university of basrah - college of medicine - basrah -IRAQ
Hypoglycaemia Biochemistry decrease in Glucose mechanismMirzaNaadir
glucose decrease due to lots of reason because there are lots of problem regerding it i detail i have given its problems and causes and symptoms and treatment also
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
2. What is Immune System?
The immune system has an remarkable defence mechanism.
It makes rapid, specific, protective against pathogenic
organism that inhabit the world in which we live.
3.
4. Immune System Functions
The immune system has evolved to protect us from pathogens.
Intracellular pathogens infect individual cells(e.g. viruses), whereas
extracellular pathogens divide extracellularly within tissues or the body
cavities (e.g. many bacteria).
Phagocytes and lymphocytes are key mediators of immunity.
Lymphocytes (B and T cells) bear receptors that recognize specific
molecular components of pathogens and have specialized functions.
B cells make antibodies, cytotoxic T lymphocytes (CTLs) kill virally
infected cells, and helper T cells coordinate the immune response by
direct cell–cell interactions and the release of cytokines.
5. Four barrier of Innate Imunnity
Physical: Skin ,Mucous Coating of Epithelium.
Physiological: Acid in Stomach, Saliva In Mouth ,Tears Of eyes.
Cellular: Certain Types OF leucocytes like Polynmorpho Nuclear
Leucocytes(PMNL),Neutrophils, monocytes leucocytes.
Cytokine: Virus infected cell secreted Protein called interferons which
protects unifected cell from virus.
6. ACQUIRED IMMUNITY OR SPECIFIC
IMMUNITY
Acquired immunity is the resistance developed in the body against
any specific foreign body like bacteria, viruses, toxins,
vaccines or transplanted tissues.
It is the most powerful immune mechanism that protects the body
from invading organisms or toxic substances. Lymphocytes are
responsible for acquired immunity.
Types of Acquired Immunity
Two types of acquired immunity develop in the body:
1. Cell mediated immunity or cellular immunity.
2. Humoral immunity.
7. DEVELOPMENT AND PROCESSING OF
LYMPHOCYTES
In fetus, lymphocytes develop from bone marrow.
All the lymphocytes are released in the circulation and are
differentiated into two categories:
1. T lymphocytes
2. B lymphocytes.
8. T. LYMPHOCYTES
T lymphocytes are processed in thymus. The processing occurs
mostly during the period between just before birth and few
months after birth. Thymus secretes thymosin which
accelerates the proliferation and activation of lymphocytes in
thymus. It also increases the activity of lymphocytes in
lymphoid tissues.
Types of T Lymphocytes
During the processing, T lymphocytes are transformed into four
types:
1. Helper T cells or inducer T cells
2. Cytotoxic T cells or killer T cells
3. Suppressor T cells
4. Memory T cells.
Storage of T Lymphocytes After the transformation, all the types
of T lymphocytes leave the thymus and are stored in lymphoid
tissues of lymph nodes, spleen, bone marrow and the GI tract.
9. B LYMPHOCYTES
B lymphocytes were first discovered in the bursa of Fabricius in
birds hence the name B lymphocytes. The bursa of Fabricius is
a lymphoid organ situated near the cloaca of birds. The bursa
is absent in mammals, and the processing of B lymphocytes
takes place in bone marrow and liver.
Types of B Lymphocytes
After processing, the B lymphocytes are transformed into two
types:
1. Plasma cells
2. Memory cells.
Storage of B Lymphocytes After the transformation, B
lymphocytes are stored in the lymphoid tissues of lymph
nodes, spleen, bone marrow and the GI tract.
10.
11. The Antigen-Antibody Reaction
the immune reaction
Involves binding antigens to antibodies
Labels a potentially dangerous antigen so it can be recognized,
and destroyed by the cells of the immune system
Antigen
any substance that the body regards as being foreign (ex.
Viruses, bacteria, toxins, & transplanted tissues)
Antibody
a disease-fighting protein created by the immune system in
response to the presence of a specific antigen (often used
interchangeably with Immunoglobulin)
13. ROLE OF HELPER T CELLS
Helper T cells are simultaneously activated by antigen. The activated helper T
cells secrete two substances called interleukin 2 and B cell growth factor,
which promote:
1. Activation of more number of B lymphocytes
2. Proliferation of plasma cells
3. Production of antibodies.
14. ANTIBODIES
An antibody is defined as a protein that is produced by B lymphocytes in response to the presence
of an antigen. Antibody is globulin in nature and it is also called immunoglobulin (Ig).
The immunoglobulins form 20 percent of the total plasma proteins.
The antibodies enter almost all the tissues of the body.
Types of Antibodies
Five types of antibodies are identified:
Among these antibodies, IgG forms 75 percent of the antibodies in the body
1. IgA (Ig alpha)
2. IgD (Ig delta)
3. IgE (Ig epsilon)
4. IgG (Ig gamma)
5. IgM (Ig mu).
15. Different Functions Of Antibodies
1. IgA plays a role in localized defense mechanism in external
secretions like tear and in mother Lactation meriod.
2. IgD is involved in recognition of the antigen by B
lymphocytes.
3. IgE is involved in allergic reactions.
4. IgG is responsible for complement fixation.
5. IgM is also responsible for complement Fixation.
16. NATURAL KILLER CELL
Natural killer (NK) cell is a large granular cell with indented nucleus. It is
considered as the third type of lymphocyte. It is not a phagocytic cell but its
granules contain hydrolytic enzymes which causes lysis of cells of invading
organisms.
The NK cell Function :
1. Destroys the viruses
2. Destroys the viral infected or damaged cells, which might form tumors
3. Destroys the malignant cells and prevents development of cancerous
tumors.
4. Secretes cytokines such as interleukin-2, interferons, colony stimulating
factor (GM-CSF) and tumor necrosis factor-
17. CYTOKINES
Cytokines are the hormone like small proteins acting as intercellular messengers
(cell signaling molecules) by binding to specific receptors of target cells.
These non antibody proteins are secreted by WBCs and some other types of
cells. Their major function is the activation and regulation of general immune
system of the body.
Cytokines are distinct from the other cell signaling molecules such as growth
factors and hormones. Cytokines are classified into several types:
1. Interleukins
2. Interferons
3. Tumor necrosis factors
4. Chemokines
5. Defensins
6. Cathelicidins
7. Platelet activating factor
18. IMMUNE DEFICIENCY DISEASES
Immune deficiency diseases are group of diseases in which some components of
immune system is missing or defective.
Normally, the defense mechanism protects the body from invading pathogenic
organism.
When the defense mechanism fails or becomes faulty (defective), the organisms
of even low virulence produce severe disease.
The organisms, which take advantage of defective defense mechanism, are
called opportunists.
The immune deficiency diseases caused by such opportunists are of two types:
1. Congenital immune deficiency diseases.
2. Acquired immune deficiency diseases.
19. CONGENIT AL IMMUNE DEFICIENCY
DISEASES
Congenital diseases are inherited and occur due to the defects in B cell,
or T cell or both. The common examples are DiGeorge's syndrome
(due to absence of thymus) and severe combined immune deficiency
(due to lymphopenia or the absence of lymphoid tissue).
20. ACQUIRED IMMUNE DEFICIENCY DISEASES
Acquired immune deficiency diseases occur due to infection by some
organisms. The most common disease of this type is acquired immune
deficiency syndrome (AIDS).
Acquired Immune Deficiency Syndrome (AIDS)
It is an infectious disease caused by immune deficiency virus (HIV).
AIDS is the most common problem throughout the world because of
rapid increase in the number of victims.
Infection occurs when a glycoprotein from HIV binds to surface
receptors of T lymphocytes, monocytes, macrophages and dendrite
cells leading to destruction of these cells.
It causes slow progressive decrease in immune function resulting in
opportunistic infections of various types.
The common opportunistic infections, which kill the AIDS patient, are
pneumonia and skin cancer.
21. Autoimmune disease
Autoimmune disease is defined as condition in which the immune system
mistakenly attacks body's own cells and tissues.
Normally, an antigen induces the immune response in the body. The
condition in which the immune system fails to give response to an antigen
is called tolerance. This is true with respect to body's own antigens that
are called self antigens or autoantigens.
This state is called autoimmunity and it leads to the activation of T
lymphocytes or production of autoantibodies from B lymphocytes.
The T lymphocytes (cytotoxic T cells) or autoantibodies attack the body's
normal cells whose surface contains the self antigen or autoantigen.
24. Prevention or Treatment for Erythroblastosis
Fetalis
If mother is found to be Rh negative and fetus is Rh positive, anti D
(antibody against D antigen) should be administered to the mother at
28th and 34th weeks of gestation as prophylactic measure.
If Rh negative mother delivers Rh positive baby, then anti D should be
administered to the mother within 48 hours of delivery.
This develops passive immunity and prevents the formation of Rh
antibodies in mother’s blood.
So the hemolytic disease of newborn does not occur in a subsequent
pregnancy.
the baby is born with erythroblastosis fetalis, the treatment is given by
means of exchange transfusion .
Rh negative blood is transfused into the infant replacing infant's own
Rh positive blood.
It will now take at least 6 months for the infant's new Rh positive blood
to replace the transfused Rh negative blood.
By this time all the molecules of Rh antibody derived from the mother
get destroyed.
26. References
Gseb 11 science sem 1 book
Immunology 7th edition David male book
www.ebscohost.com(articles)
Fundamental immunology( Lippincott’s William and Wilkins)
http://ib.bioninja.com.au/higher-level/topic-11-animal-physiology/111-
antibody-production-and/types-of-immunity.html
Google Images